Global Iliac Stents Market Size, Share, and Industry Analysis by Stent Type, by Artery Lesions, by Material Type, and by End-use- Growth and Trend Forecast, 2026-2035

The iliac stents market was estimated at USD 1,208.55 million in 2025 and is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2026 to 2035. The market is fuelled by the growing incidence of peripheral artery disease (PAD), the increasing adoption of minimally invasive endovascular procedures, and improvements in stent technology.

Published: March 25, 2026
100 Pages

Market Overview

The American Heart Association reports that over 8 million Americans suffered from peripheral artery disease in 2022, indicating an increasing number of patients in need of endovascular procedures such as iliac stenting.

The iliac stents market has grown steadily over the past decade due to the increasing use of minimally invasive endovascular procedures. Long-term patency and clinical results have been improved by advances in stent design, such as increased flexibility and endurance. For instance, in 2021, Medtronic expanded its vascular portfolio with advanced peripheral stent systems, supporting the growing adoption of iliac stenting procedures.

The market for iliac stents is anticipated to rise steadily over the forecast period due to the growing need for minimally invasive vascular procedures and continuous advances in stent durability and function. For instance, Boston Scientific is anticipated to develop peripheral stent technologies with improved flexibility and drug-eluting capabilities by 2030, providing improved long-term results in iliac artery treatments.

Iliac Stents Market Overview

Base Year Market Size (2025): USD 1,208.55 Million

CAGR: 6.5%

Forecast Year Market Size (2035): USD 2,249.40 Million

Leading Region: North America

Emerging Countries: India, Brazil, China, Mexico, and South Africa

Major Players:

  • Abbott Laboratories

  • Boston Scientific Corporation

  • Medtronic

  • W. L. Gore & Associates

  • Terumo Corporation

Iliac Stents Market Trends

The iliac stents market is changing due to improvements in vascular technologies and a rise in the use of minimally invasive procedures.

· The increasing inclination towards minimally invasive endovascular treatments is a major trend, offering reduced recovery time and lower complication risks compared to open surgeries.

· Flexibility, durability, and long-term patency rates are being improved by technological developments in stent design, including self-expanding and coated stents.

· The development of innovative material-based and drug-eluting stents involves lowering the chance of restenosis and improving the efficacy of treatment.

· Furthermore, increasing the use of precision-guided therapies and advanced imaging is enhancing clinical results and procedural precision in iliac artery procedures.

Collectively, these trends are driving the market toward more efficient, minimally invasive, and technologically advanced iliac stent solutions, supporting its long-term growth.

Iliac Stents Market Analysis

By Stent Type

Self-expandable stents ensure efficient and long-lasting iliac artery support by providing exceptional flexibility and adaptability to vessel anatomy.

Based on stent type, the iliac stents market is segmented into self-expandable stents, balloon-expandable stents, and others. The self-expandable stents segment dominated the market with the largest revenue share of 60.46% in 2025.

By Artery Lesions

Common iliac artery lesions represent the most frequently treated vascular conditions, requiring effective stenting for restoring blood flow.

Based on artery lesions, the iliac stents market is segmented into common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. The common iliac artery lesions segment accounted for the largest revenue share in 2025.

By Material Type

Nitinol offers excellent flexibility and shape memory, making it ideal for self-expandable stents in dynamic vascular environments.

Based on material type, the iliac stents market is segmented into nitinol, stainless steel, cobalt-chromium alloys, and covered fabric. The nitinol segment accounted for the largest revenue share in 2025.

By End-use

Hospitals offer advanced vascular intervention facilities and specialized expertise for complex iliac stenting procedures

Based on end-use, the iliac stents market is divided into hospitals, outpatient facilities, and others. In 2025, the hospitals segment had the highest revenue share.

Regional Analysis

North America benefits from early adoption of sophisticated iliac stenting procedures and a well-developed vascular care infrastructure.

In 2025, the iliac stents market was dominated by North America, with a revenue share of 43.96%.

Europe is progressing with the growing use of innovative vascular treatment approaches and expanding endovascular capabilities.

Growing usage of minimally invasive stenting treatments, improved healthcare infrastructure, and more awareness of peripheral artery disease are all likely to contribute to Europe's significant rise throughout the projection period.

Key Companies Profiled

The competitive landscape of the iliac stents market is characterized by the presence of established medical device companies and emerging vascular technology providers. Leading companies with substantial market shares include Abbott Laboratories, Boston Scientific Corporation, Medtronic, W. L. Gore & Associates, and Terumo Corporation. These companies' robust product portfolios and ongoing advancements in stent technologies underpin their positions. For instance, W. L. Gore & Associates' sophisticated iliac stent graft system was approved by regulators in 2024, increasing its use in intricate vascular procedures.

Iliac Stents Market Companies:

  • Abbott Laboratories

  • B. Braun SE

  • Becton, Dickinson and Company (BD)

  • Biotronik SE & Co. KG

  • Boston Scientific Corporation

  • Cook Medical

  • Getinge AB

  • iVascular

  • Medtronic plc

  • Terumo Corporation

  • W. L. Gore & Associates, Inc.

Market Segmentation

This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the iliac stents market by-

  • Stent Type (Revenue in USD Million, 2021 - 2035)

    • Self-expandable Stents

    • Balloon-expandable Stents

    • Others

  • Artery Lesions (Revenue in USD Million, 2021 - 2035)

    • Common Iliac Artery Lesions

    • Severe Calcified Lesions

    • Complete Obstructive Lesions

  • Material Type (Revenue in USD Million, 2021 – 2035)

    • Nitinol (most common for self-expandable)

    • Stainless steel

    • Cobalt-chromium alloys

    • Covered Fabric

  • End-use (Revenue in USD Million, 2021 – 2035)

    • Hospitals

    • Outpatient Facilities

    • Others

  • Regional (Revenue in USD Million, 2021 - 2035)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

      • Switzerland

      • Netherlands

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • Thailand

      • South Korea

      • Indonesia

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Consumer Behaviour Analysis

3.5. Value Chain Analysis

3.6. Technology Roadmap

3.7. Porters Analysis

3.8. PESTLE Analysis

4. Market Estimates and Forecasts, By Stent Type, 2021 - 2035 (Market Size in USD Mn)

4.1. Self-expandable Stents

4.2. Balloon-expandable Stents

4.3. Others

5. Market Estimates and Forecasts, By Artery Lesions, 2021 – 2035 (USD Mn)

5.1. Common Iliac Artery Lesions

5.2. Severe Calcified Lesions

5.3. Complete Obstructive Lesions

6. Market Estimates and Forecasts, By Material Type, 2021 – 2035 (USD Mn)

6.1. Nitinol (most common for self-expandable)

6.2. Stainless steel

6.3. Cobalt-chromium alloys

6.4. Covered Fabric

7. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)

7.1. Hospitals

7.2. Outpatient Facilities

7.3. Others

8. Market Estimates and Forecasts, By Region, 2021 - 2035 (USD Mn)

8.1. North America

8.1.1. U.S.

8.1.1.1. U.S. Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.1.1.2. Market Dynamics

8.1.1.3. Competitive Landscape

8.1.1.4. Regulatory Framework

8.1.1.5. Reimbursement Scenario

8.1.2. Canada

8.1.2.1. Canada Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.1.2.2. Market Dynamics

8.1.2.3. Competitive Landscape

8.1.2.4. Regulatory Framework

8.1.2.5. Reimbursement Scenario

8.2. Europe

8.2.1. Germany

8.2.1.1. Germany Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.1.2. Market Dynamics

8.2.1.3. Competitive Landscape

8.2.1.4. Regulatory Framework

8.2.1.5. Reimbursement Scenario

8.2.2.

8.2.3. U.K.

8.2.3.1. UK Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.3.2. Market Dynamics

8.2.3.3. Competitive Landscape

8.2.3.4. Regulatory Framework

8.2.3.5. Reimbursement Scenario

8.2.4. France

8.2.4.1. France Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.4.2. Market Dynamics

8.2.4.3. Competitive Landscape

8.2.4.4. Regulatory Framework

8.2.4.5. Reimbursement Scenario

8.2.5. Italy

8.2.5.1. Italy Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.5.2. Market Dynamics

8.2.5.3. Competitive Landscape

8.2.5.4. Regulatory Framework

8.2.5.5. Reimbursement Scenario

8.2.6. Spain

8.2.6.1. Spain Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.6.2. Market Dynamics

8.2.6.3. Competitive Landscape

8.2.6.4. Regulatory Framework

8.2.6.5. Reimbursement Scenario

8.2.7. Sweden

8.2.7.1. Sweden Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.7.2. Market Dynamics

8.2.7.3. Competitive Landscape

8.2.7.4. Regulatory Framework

8.2.7.5. Reimbursement Scenario

8.2.8. Norway

8.2.8.1. Norway Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.8.2. Market Dynamics

8.2.8.3. Competitive Landscape

8.2.8.4. Regulatory Framework

8.2.8.5. Reimbursement Scenario

8.2.9. Denmark

8.2.9.1. Denmark Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.9.2. Market Dynamics

8.2.9.3. Competitive Landscape

8.2.9.4. Regulatory Framework

8.2.9.5. Reimbursement Scenario

8.2.10. Switzerland

8.2.10.1. Switzerland Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.10.2. Market Dynamics

8.2.10.3. Competitive Landscape

8.2.10.4. Regulatory Framework

8.2.10.5. Reimbursement Scenario

8.2.11. Netherlands

8.2.11.1. Netherlands Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.11.2. Market Dynamics

8.2.11.3. Competitive Landscape

8.2.11.4. Regulatory Framework

8.2.11.5. Reimbursement Scenario

8.2.12. Rest of Europe

8.2.12.1. Rest of Europe Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.2.12.2. Market Dynamics

8.2.12.3. Competitive Landscape

8.2.12.4. Regulatory Framework

8.2.12.5. Reimbursement Scenario

8.3. Asia Pacific

8.3.1. China

8.3.1.1. China Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.1.2. Market Dynamics

8.3.1.3. Competitive Landscape

8.3.1.4. Regulatory Framework

8.3.1.5. Reimbursement Scenario

8.3.2. Japan

8.3.2.1. Japan Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.2.2. Market Dynamics

8.3.2.3. Competitive Landscape

8.3.2.4. Regulatory Framework

8.3.2.5. Reimbursement Scenario

8.3.3. India

8.3.3.1. India Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.3.2. Market Dynamics

8.3.3.3. Competitive Landscape

8.3.3.4. Regulatory Framework

8.3.3.5. Reimbursement Scenario

8.3.4. Australia

8.3.4.1. Australia Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.4.2. Market Dynamics

8.3.4.3. Competitive Landscape

8.3.4.4. Regulatory Framework

8.3.4.5. Reimbursement Scenario

8.3.5. South Korea

8.3.5.1. South Korea Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.5.2. Market Dynamics

8.3.5.3. Competitive Landscape

8.3.5.4. Regulatory Framework

8.3.5.5. Reimbursement Scenario

8.3.6. Thailand

8.3.6.1. Thailand Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.6.2. Market Dynamics

8.3.6.3. Competitive Landscape

8.3.6.4. Regulatory Framework

8.3.6.5. Reimbursement Scenario

8.3.7. Indonesia

8.3.7.1. Indonesia Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.7.2. Market Dynamics

8.3.7.3. Competitive Landscape

8.3.7.4. Regulatory Framework

8.3.7.5. Reimbursement Scenario

8.3.8. Rest of Asia Pacific

8.3.8.1. Rest of Asia Pacific Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.3.8.2. Market Dynamics

8.3.8.3. Competitive Landscape

8.3.8.4. Regulatory Framework

8.3.8.5. Reimbursement Scenario

8.4. Latin America

8.4.1. Brazil

8.4.1.1. Brazil Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.4.1.2. Market Dynamics

8.4.1.3. Competitive Landscape

8.4.1.4. Regulatory Framework

8.4.1.5. Reimbursement Scenario

8.4.2. Mexico

8.4.2.1. Mexico Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.4.2.2. Market Dynamics

8.4.2.3. Competitive Landscape

8.4.2.4. Regulatory Framework

8.4.2.5. Reimbursement Scenario

8.4.3. Argentina

8.4.3.1. Argentina Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.4.3.2. Market Dynamics

8.4.3.3. Competitive Landscape

8.4.3.4. Regulatory Framework

8.4.3.5. Reimbursement Scenario

8.4.4. Colombia

8.4.4.1. Colombia Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.4.4.2. Market Dynamics

8.4.4.3. Competitive Landscape

8.4.4.4. Regulatory Framework

8.4.4.5. Reimbursement Scenario

8.5. Middle East and Africa

8.5.1. South Africa

8.5.1.1. South Africa Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.5.1.2. Market Dynamics

8.5.1.3. Competitive Landscape

8.5.1.4. Regulatory Framework

8.5.1.5. Reimbursement Scenario

8.5.2. Saudi Arabia

8.5.2.1. Saudi Arabia Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.5.2.2. Market Dynamics

8.5.2.3. Competitive Landscape

8.5.2.4. Regulatory Framework

8.5.2.5. Reimbursement Scenario

8.5.3. UAE

8.5.3.1. UAE Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.5.3.2. Market Dynamics

8.5.3.3. Competitive Landscape

8.5.3.4. Regulatory Framework

8.5.3.5. Reimbursement Scenario

8.5.4. Kuwait

8.5.4.1. Kuwait Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.5.4.2. Market Dynamics

8.5.4.3. Competitive Landscape

8.5.4.4. Regulatory Framework

8.5.4.5. Reimbursement Scenario

8.5.5. Rest of Middle East and Africa

8.5.5.1. Rest of MEA Iliac Stents Market Estimates and Forecasts to 2035 (USD Mn)

8.5.5.2. Market Dynamics

8.5.5.3. Competitive Landscape

8.5.5.4. Regulatory Framework

8.5.5.5. Reimbursement Scenario

9. Competitive Landscape

9.1. Company Market Share Analysis, 2024

9.2. Company Tier Structure

9.3. List of Major Suppliers, By Key Countries

9.4. Key Company Positioning Analysis

9.5. Company Profile

9.5.1. Abbott Laboratories

9.5.2. B. Braun SE

9.5.3. Becton, Dickinson and Company (BD)

9.5.4. Biotronik SE & Co. KG

9.5.5. Boston Scientific Corporation

9.5.6. Cook Medical

9.5.7. Getinge AB

9.5.8. iVascular

9.5.9. Medtronic plc

9.5.10. Terumo Corporation

9.5.11. W. L. Gore & Associates, Inc.

9.6. Key Development Strategies

9.6.1. New Product Launches

9.6.2. Mergers and Acquisition

9.6.3. Partnerships and Collaborations

9.6.4. Expansion Plans

10. Analyst Perspective

11. Related Reports

Related Research

Global Hyaluronic Acid-Based Dermal Fillers Market Size, Share, and Industry Analysis- by Product Type, by Gender, by Elasticity Module, by Application, and by End-use, Growth and Trend Forecast, 2026 – 2035

April 23, 2026View

Global Non-invasive Fat Reduction Market Size, Share, and Industry Forecast – by Product Type, by Application, by Gender, and by End-use- Growth and Forecast, 2026- 2035

April 23, 2026View

Global Wound Care Market Size, Share, and Industry Analysis – by Product Type, by Wound Type, and by End-use – Growth and Trend Forecast, 2026 -2035

April 22, 2026View

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.